Steven Cohen Blueprint Medicines Corp Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 501,581 shares of BPMC stock, worth $46.4 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

501,581

Previous 501,581 -0.0%

Holding current value

$46.4 Million

Previous $54.1 Million -0.0%

% of portfolio

0.15%

Previous 0.15%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $18.9 Million - $24.1 Million	221,813 Added 79.28%	501,581 $54.1 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $17.5 Million - $23.9 Million	239,333 Added 591.9%	279,768 $26.5 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $24.4 Million - $51.6 Million	-555,365 Reduced 93.21%	40,435 $3.73 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $27.9 Million - $39.3 Million	595,800 New	595,800 $29.9 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $7.8 Million - $12.1 Million	172,482 New	172,482 $8.71 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $39.4 Million - $48.5 Million	-418,200 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $12.7 Million - $17.2 Million	157,356 Added 60.33%	418,200 $43 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $21.6 Million - $26.3 Million	260,844 New	260,844 $22.9 Million
Q1 2020 May 15, 2020	SELL	$48.11 - $82.22 $10.1 Million - $17.2 Million	-209,729 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $14 Million - $17.3 Million	209,729 New	209,729 $16.8 Million
Q2 2018 Aug 14, 2018	SELL	$60.96 - $101.18 $17.1 Million - $28.3 Million	-279,957 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $1.32 Million - $1.86 Million	-18,052 Reduced 6.06%	279,957 $25.7 Million
Q4 2017 Feb 14, 2018	SELL	$62.91 - $88.32 $1.14 Million - $1.61 Million	-18,191 Reduced 5.75%	298,009 $22.5 Million
Q3 2017 Nov 14, 2017	BUY	$42.37 - $69.67 $13.4 Million - $22 Million	316,200	316,200 $22 Million

Others Institutions Holding BPMC

# of Institutions

340

Shares Held

62M

Call Options Held

987K

Put Options Held

578K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.52B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account